Citius Pharmaceuticals, Inc. Secures $3.6 Million Through New Jersey Economic Development Program
Amount Raised
$3.6 Million
Round Type
Seed
CranfordBiotechnologyHealthcareHealth CarePharmaceuticalBiopharmaCall CenterDescription
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that the Company has been selected to participate in New Jersey's Technology Business Tax Certificate Transfer (NOL) Program, more commonly known as the Net Operating Loss (NOL) Program, and will receive $3.6 million in non-dilutive capital through the New Jersey Economic Development Authority (NJEDA). Citius expects to receive the funds by late 2022 or early 2023.
Quick answer
Citius Pharmaceuticals, Inc. raised $3.6 Million in a Seed round, dated November 21, 2022. Citius Pharmaceuticals, Inc. is based in Cranford, New Jersey, United States.
- How much did Citius Pharmaceuticals, Inc. raise?
- Citius Pharmaceuticals, Inc. raised $3.6 Million in a Seed round on November 21, 2022.
- What does Citius Pharmaceuticals, Inc. do?
- To learn more about NJEDA resources for businesses call NJEDA Customer Care at 609-858-6767 or visit https://www.njeda.com and follow @NewJerseyEDA on Facebook, Twitter, Instagram, and LinkedIn.
- Where is Citius Pharmaceuticals, Inc. based and how big is it?
- Citius Pharmaceuticals, Inc. is based in Cranford, New Jersey, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Pharmaceutical around the same time
Companies in the same sectors as Citius Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Os Therapies raised $2M on November 16, 2022.
- MBX Biosciences, Inc. raised $47M on November 7, 2022.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
Who to call at Citius Pharmaceuticals, Inc., and when
A new round usually means Citius Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Citius Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Citius Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Citius Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Citius Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Citius Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.